Augpac: Infections Caused by Amoxicillin-Resistant Organisms Producing β-Lactamases Sensitive to Clavulanic Acid: Upper Respiratory Tract Infections: Otitis media, tonsillitis, sinusitis.
Lower Respiratory Tract Infections: Bronchitis (caused by amoxicillin-resistant β-lactamases producing E. coli, H. influenzae and H. parainfluenzae), pneumonia.
Urinary Tract Infections: Cystitis, urethritis, pyelonephritis.
Skin and soft tissue infections.
Amoxicillin and clavulanate potassium formulations will also be effective in the treatment of infections caused by amoxicillin-sensitive organisms at the appropriate amoxicillin dosage since in this situation, the clavulanic acid component does not contribute to the therapeutic effect.
Augpac Injection: Upper respiratory tract infections, e.g. otitis media, sinusitis. Lower respiratory tract infections, e.g. bronchitis. Genito-urinary tract infections, e.g. cystitis, urethritis. Skin and soft tissues infections, e.g. severe dental abscess, wound infections, cellulitis.